{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T19:18:28Z","timestamp":1648581508289},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,5,5]],"date-time":"2010-05-05T00:00:00Z","timestamp":1273017600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Oper Res"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1007\/s10479-010-0741-y","type":"journal-article","created":{"date-parts":[[2010,5,4]],"date-time":"2010-05-04T15:11:47Z","timestamp":1272985907000},"page":"683-705","source":"Crossref","is-referenced-by-count":1,"title":["Scheduling the adjuvant endocrine therapy for early stage breast cancer"],"prefix":"10.1007","volume":"196","author":[{"given":"Sera","family":"Kahruman","sequence":"first","affiliation":[]},{"given":"Elif","family":"Ulusal","sequence":"additional","affiliation":[]},{"given":"Sergiy","family":"Butenko","sequence":"additional","affiliation":[]},{"given":"Illya V.","family":"Hicks","sequence":"additional","affiliation":[]},{"given":"Kathleen M.","family":"Diehl","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2010,5,5]]},"reference":[{"key":"741_CR1","unstructured":"American Cancer Society (2009). Cancer reference information. http:\/\/www.cancer.org ."},{"issue":"5","key":"741_CR2","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1287\/opre.1060.0320","volume":"54","author":"Z. Agur","year":"2006","unstructured":"Agur, Z., Hassin, R., & Levy, S. (2006). Optimizing chemotherapy scheduling using local search heuristics. Operations Research, 54(5), 829\u2013846.","journal-title":"Operations Research"},{"key":"741_CR3","first-page":"1","volume":"364","author":"ATAC Trialist Group","year":"2004","unstructured":"ATAC Trialist Group (2004). Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years\u2019 adjuvant treatment of breast cancer. Lancet, 364, 1\u20133.","journal-title":"Lancet"},{"key":"741_CR4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0010-4825(00)00032-9","volume":"31","author":"D. Barbolosi","year":"2001","unstructured":"Barbolosi, D., & Iliadis, A. (2001). Optimizing drug regimens in cancer chemotherapy: a\u00a0simulation study using a pk-pd model. Computers in Biology and Medicine, 31, 157\u2013172.","journal-title":"Computers in Biology and Medicine"},{"key":"741_CR5","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/imammb\/18.4.343","volume":"18","author":"D. R. Beil","year":"2001","unstructured":"Beil, D. R., & Wein, L. M. (2001). Analysis and comparison of multimodal cancer treatments. IMA Journal of Mathematics Applied in Medicine and Biology, 18, 343\u2013376.","journal-title":"IMA Journal of Mathematics Applied in Medicine and Biology"},{"key":"741_CR6","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0140-6736(00)02677-5","volume":"356","author":"L. Bergman","year":"2000","unstructured":"Bergman, L., Beelen, M., Gallee, M. P., Hollema, H., Benraadt, J., & van Leeuwen, F. (2000). Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Lancet, 356, 881\u2013887.","journal-title":"Lancet"},{"key":"741_CR7","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0140-6736(05)67059-6","volume":"366","author":"F. Boccardo","year":"2005","unstructured":"Boccardo, F., Rubagotti, A., Puntoni, M., et al. (2005). Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: preliminary results of the Italian tamoxifen anastrozole trial. Lancet, 366, 455\u2013462.","journal-title":"Lancet"},{"issue":"2","key":"741_CR8","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0360-3016(00)01501-7","volume":"49","author":"A. Brahme","year":"2001","unstructured":"Brahme, A. (2001). Individualizing cancer treatment: biological optimization models in treatment planning and delivery. International Journal of Radiation Oncology, Biology, Physics, 49(2), 327\u2013337.","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"26","key":"741_CR9","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1056\/NEJMoa052258","volume":"353","author":"Breast International Group (BIG) 1-98 Collaborative Group","year":"2005","unstructured":"Breast International Group (BIG) 1-98 Collaborative Group (2005). A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer. New England Journal of Medicine, 353(26), 2747\u20132757.","journal-title":"New England Journal of Medicine"},{"key":"741_CR10","unstructured":"Buzdar, A. U. (2005). Aromatase inhibitors in the adjuvant treatment of breast cancer. ASBD Breast Healthcare Update."},{"key":"741_CR11","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1056\/NEJMoa040331","volume":"350","author":"R. C. Coombes","year":"2004","unstructured":"Coombes, R. C., Hall, E., Gibson, L.J., et al. (2004). A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. New England Journal of Medicine, 350, 1081\u20131092.","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"741_CR12","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/sj.bjc.6602964","volume":"94","author":"J. Cuzick","year":"2006","unstructured":"Cuzick, J., Sasieni, P., & Howell, A. (2006). Should aromatase inhibitors be used as initial adjuvant treatment or sequenced after tamoxifen? British Journal of Cancer, 94(4), 460\u2013464.","journal-title":"British Journal of Cancer"},{"issue":"2","key":"741_CR13","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/humrep\/dei322","volume":"21","author":"S. Duffy","year":"2006","unstructured":"Duffy, S., Jackson, T., Lansdown, M., Philips, K., Wells, M., Pollard, S., Clack, G., Coibion, M., & Bianco,\u00a0A. (2006). The ATAC (\u2018Arimidex\u2019, Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: first results of the endometrial sub-protocol following 2 years of treatment. Human Reproduction, 21(2), 545\u2013553.","journal-title":"Human Reproduction"},{"key":"741_CR14","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0140-6736(97)11423-4","volume":"351","author":"Early Breast Cancer Trialist\u2019s Collaborative Group","year":"1998","unstructured":"Early Breast Cancer Trialist\u2019s Collaborative Group (1998). Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet, 351, 1451\u20131467.","journal-title":"Lancet"},{"key":"741_CR15","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1200\/JCO.2004.08.029","volume":"22","author":"L. Fallowfield","year":"2004","unstructured":"Fallowfield, L., Cella, D., Cuzick, J., Francis, S., Locker, G., & Howell, A. (2004). Quality of life of postmenopausal women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) adjuvant breast cancer trial. Journal of Clinical Oncology, 22, 4261\u20134271.","journal-title":"Journal of Clinical Oncology"},{"key":"741_CR16","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1200\/JCO.2005.03.3654","volume":"24","author":"L. J. Fallowfield","year":"2006","unstructured":"Fallowfield, L. J., Bliss, J. M., Porter, L. S., Price, M. H., Snowdon, C. F., Jones, S. E., Coombes, R. C., & Hall, E. (2006). Quality of life in the intergroup exemestane study: a randomized trial of exemestane versus continued tamoxifen after 2 to 3 years of tamoxifen in postmenopausal women with primary breast cancer. Journal of Clinical Oncology, 24, 910\u2013917.","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"741_CR17","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1137\/S105262340139745X","volume":"13","author":"M. C. Ferris","year":"2003","unstructured":"Ferris, M. C., Lim, J., & Shepard, D. M. (2003). An optimization approach for radiosurgery treatment planning. SIAM Journal on Optimization, 13(3), 921\u2013937.","journal-title":"SIAM Journal on Optimization"},{"key":"741_CR18","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1137\/S0036139998338509","volume":"60","author":"K. R. Fister","year":"2000","unstructured":"Fister, K. R., & Panetta, J. C. (2000). Optimal control applied to cell-cycle-specific cancer chemotherapy. SIAM Journal of Applied Mathematics, 60, 1059\u20131072.","journal-title":"SIAM Journal of Applied Mathematics"},{"key":"741_CR19","first-page":"1793\u20131802","volume":"349","author":"P. E. Goss","year":"2003","unstructured":"Goss, P. E., Ingle, J. N., Martino, S., et al. (2003). A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer. New England Journal of Medicine, 349, 1793\u20131802.","journal-title":"New England Journal of Medicine"},{"issue":"17","key":"741_CR20","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/jnci\/dji250","volume":"97","author":"P. E. Goss","year":"2005","unstructured":"Goss, P. E., Ingle, J. N., Martino, S., et al. (2005). Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17. Journal of the National Cancer Institute, 97(17), 1262\u20131271.","journal-title":"Journal of the National Cancer Institute"},{"key":"741_CR21","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0166-218X(01)00261-X","volume":"118","author":"H. Hamacher","year":"2002","unstructured":"Hamacher, H., & K\u00fcfer, K. (2002). Inverse radiation therapy planning\u2014a multiple objective optimization approach. Discrete Applied Mathematics, 118, 145\u2013161.","journal-title":"Discrete Applied Mathematics"},{"key":"741_CR22","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0140-6736(05)67059-6","volume":"366","author":"R. Jakesz","year":"2005","unstructured":"Jakesz, R., & Menzel, C. (2005). Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years\u2019 adjuvant tamoxifen: combined results of abcsg trial 8 and arno 95 trial. Lancet, 366, 455\u2013462.","journal-title":"Lancet"},{"issue":"22","key":"741_CR23","doi-asserted-by":"crossref","first-page":"5138","DOI":"10.1200\/JCO.2005.04.120","volume":"23","author":"R. Jakesz","year":"2005","unstructured":"Jakesz, R., Jonat, W., Grant, M., et al. (2005). Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years\u2019 adjuvant tamoxifen: combined results of ABCSG Trial 8 and ARNO 95 Trial. Journal of Clinical Oncology, 23(22), 5138\u20135147.","journal-title":"Journal of Clinical Oncology"},{"key":"741_CR24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1023\/A:1022938707934","volume":"119","author":"E. K. Lee","year":"2003","unstructured":"Lee, E. K., Fox, T., & Crocker, I. (2003). Integer programming applied to intensity-modulated radiation therapy treatment planning. Annals of Operations Research, 119, 165\u2013181.","journal-title":"Annals of Operations Research"},{"key":"741_CR25","unstructured":"National Cancer Institute (2008). Aromatase inhibitors come of age. http:\/\/www.cancer.gov . Accessed January 2008."},{"key":"741_CR26","unstructured":"Neos Server for Optimization (2008). http:\/\/www-neos.mcs.anl.gov\/ . Accessed January 2008."},{"key":"741_CR27","doi-asserted-by":"crossref","first-page":"5178","DOI":"10.1200\/JCO.2005.02.964","volume":"23","author":"R. S. Punglia","year":"2005","unstructured":"Punglia, R. S., Kuntz, K. M., Winer, E. P., Weeks, J. C., & Burstein, H. J. (2005). Optimizing adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer: a\u00a0decision analysis. Journal of Clinical Oncology, 23, 5178\u20135187.","journal-title":"Journal of Clinical Oncology"},{"key":"741_CR28","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1287\/opre.1050.0261","volume":"54","author":"H. E. Romeijn","year":"2006","unstructured":"Romeijn, H. E., Ahuja, R. K., Dempsey, J. F., & Kumar, A. (2006). A new linear programming approach to radiation therapy treatment planning problems. Operations Research, 54, 201\u2013216.","journal-title":"Operations Research"},{"issue":"10","key":"741_CR29","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1200\/JCO.1996.14.10.2738","volume":"14","author":"T. Saphner","year":"1996","unstructured":"Saphner, T., Tormey, D. C., & Gray, R. (1996). Annual hazard rates of recurrence for breast cancer after primary therapy. Journal of Clinical Oncology, 14(10), 2738\u20132746.","journal-title":"Journal of Clinical Oncology"},{"key":"741_CR30","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0025-5564(82)90024-4","volume":"59","author":"K. G. Shin","year":"1982","unstructured":"Shin, K. G., & Pado, R. (1982). Design of optimal cancer chemotherapy using a continuous-time state model of cell kinetics. Mathematical Biosciences, 59, 225\u2013248.","journal-title":"Mathematical Biosciences"},{"key":"741_CR31","unstructured":"Th\u00fcrliman, B. (2005). Letrozole vs. tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive breast cancer. BIG 1-98: a prospective randomized double-blind phase III study. St. Gallen, Switzerland."}],"container-title":["Annals of Operations Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10479-010-0741-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10479-010-0741-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10479-010-0741-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T18:08:01Z","timestamp":1559153281000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10479-010-0741-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,5]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["741"],"URL":"https:\/\/doi.org\/10.1007\/s10479-010-0741-y","relation":{},"ISSN":["0254-5330","1572-9338"],"issn-type":[{"value":"0254-5330","type":"print"},{"value":"1572-9338","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,5]]}}}